Workflow
Zheng Quan Shi Bao
icon
Search documents
市场监管总局回应“南极磷虾油”问题
Zheng Quan Shi Bao· 2025-12-25 12:24
市场监管总局:针对"南极磷虾油"问题将强化食品委托生产监管。 据新华社消息,市场监管总局25日回应,"南极磷虾油"事件暴露出企业委托生产加工行为不规范等问 题。一些企业借助企业品牌影响力,仅关注销售利润却不对产品质量进行把关,甚至纵容被委托企业制 售不合格产品。 据介绍,市场监管总局近期将发布《食品委托生产监督管理办法》,将商标授权、特许经营、来料加 工、定制生产等方式进行委托生产食品的情形纳入监督管理,明确细化委托双方食品安全责任,健全相 关监管制度要求。 市场监管总局将指导地方市场监管部门,加强对类似同仁堂贴牌加工等方式委托生产食品行为的监管。 近期将组织开展专项抽检,对市场上的磷虾油、鱼油等产品加大监督抽检力度,严厉打击相关违法行 为。 今年12月11日,"上海市消保委"微信公众号发文称,知名企业疑似造假,将被上海市消保委约谈。相关 文章称,一款标称"北京同仁堂99%高纯南极磷虾油"的产品,在网页上写着"高含量""智利进口原料""高 度提纯""1粒≈100只磷虾",其磷脂标识值为43%,看似是品质出众的优质产品,但检测结果显示该款产 品磷脂含量为0。这款产品由安徽哈博药业有限公司生产、同仁堂四川健康药业 ...
大业股份涨停,上榜营业部合计净卖出4380.10万元
Zheng Quan Shi Bao· 2025-12-25 11:18
大业股份(603278)今日涨停,全天换手率18.87%,成交额7.21亿元,振幅12.03%。龙虎榜数据显示,营 业部席位合计净卖出4380.10万元。 上交所公开信息显示,当日该股因日涨幅偏离值达9.55%上榜,营业部席位合计净卖出4380.10万元。 证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交2.13亿元,其中,买入成交额为8436.15 万元,卖出成交额为1.28亿元,合计净卖出4380.10万元。 资金流向方面,今日该股主力资金净流入6737.11万元,其中,特大单净流入6945.41万元,大单资金净 流出208.30万元。近5日主力资金净流入1.85亿元。 10月30日公司发布的三季报数据显示,前三季度公司共实现营业收入37.78亿元,同比下降1.60%,实现 净利润2337.52万元,同比增长121.71%。 大业股份12月25日交易公开信息 买/卖会员营业部名称买入金额(万元)卖出金额(万元) 买一 东亚前海证券有限责任公司苏州分公司 2053.64 买二 国金证券股份有限公司成都新都区马超西路证券营业部 2044.78 买三 中国银河证券股份有限公司厦门嘉禾路证券营业部 153 ...
信达生物免疫药物达伯欣®获批 为首个国产获批上市的抗CTLA-4抑制剂
Zheng Quan Shi Bao· 2025-12-25 11:12
Core Viewpoint - The approval of the anti-CTLA-4 monoclonal antibody Daberxin® (Ipilimumab N01 injection) by the National Medical Products Administration (NMPA) marks a significant breakthrough in the treatment of resectable IIB-III stage microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) colorectal cancer patients in China, establishing it as the first domestically developed anti-CTLA-4 inhibitor approved for this indication [1][2]. Group 1 - Daberxin® is now the first domestically approved anti-CTLA-4 inhibitor in China, representing a global first for a "dual immunotherapy" neoadjuvant treatment regimen for colorectal cancer [1][2]. - Approximately 15% of resectable colorectal cancer patients are classified as MSI-H/dMMR, who have historically lacked effective pre-surgical treatment options, often relying on "surgery + chemotherapy" with high recurrence risks [1]. - The NeoShot-III study demonstrated that 82% of the first 50 patients receiving the "dual immunotherapy" neoadjuvant treatment achieved pathological complete response (pCR), with a 100% surgical resection rate and no additional safety risks compared to direct surgery [2]. Group 2 - As of 2025, the company has successfully launched seven innovative drugs, with significant products or key data emerging in oncology, metabolism, autoimmune diseases, and ophthalmology [3]. - The company is transitioning from a single-focus on oncology to a dual-driven approach encompassing both oncology and chronic diseases, aiming to establish a comprehensive commercialization platform in the chronic disease sector [3]. - The company targets to exceed 20 billion yuan in product revenue by 2027, supported by the continued growth of chronic disease products and stable contributions from core oncology products [3].
柏诚股份换手率32.44%,上榜营业部合计净卖出3981.83万元
Zheng Quan Shi Bao· 2025-12-25 10:02
Core Viewpoint - The stock of 柏诚股份 (601133) experienced a 2.12% increase today, with a turnover rate of 32.44% and a trading volume of 844 million yuan, despite a net sell-off of 39.82 million yuan by brokerage seats [1][2]. Trading Activity - The stock was listed on the trading board due to its turnover rate reaching 32.44%, with a total net sell-off of 39.82 million yuan from brokerage seats [1]. - The top five brokerage seats accounted for a total transaction of 123 million yuan, with a buying amount of 41.55 million yuan and a selling amount of 81.37 million yuan, resulting in a net sell-off of 39.82 million yuan [1]. - The largest buying brokerage was 国泰海通证券股份有限公司总部, with a purchase amount of 12.33 million yuan, while the largest selling brokerage was 高盛(中国)证券, selling 29.29 million yuan [1][3]. Fund Flow - The stock saw a net outflow of 11.63 million yuan in principal funds today, with a net inflow of 5.96 million yuan from large orders and a net outflow of 17.58 million yuan from major orders [2]. - Over the past five days, the stock has seen a net inflow of 16.54 million yuan in principal funds [2]. Margin Trading - As of December 24, the stock's margin trading balance was 237 million yuan, with a financing balance of 237 million yuan and a securities lending balance of 386,300 yuan [2]. - The financing balance increased by 25.04 million yuan over the past five days, representing an increase of 11.81%, while the securities lending balance increased by 384,800 yuan, showing a significant increase of 25,298.29% [2]. Financial Performance - According to the third-quarter report released on October 29, the company achieved a total revenue of 3.276 billion yuan in the first three quarters, a year-on-year decrease of 14.63%, and a net profit of 133 million yuan, down 16.22% year-on-year [2].
头部硅片企业今日大幅上调报价?硅片厂商回应
Zheng Quan Shi Bao· 2025-12-25 09:42
根据行业咨询机构InfoLink的数据,本周各型号硅片均价涨幅在3.3%—9.8%之间。该机构指出,在多数硅片企业预期价格仍有进一步上调空间的情况下,现 阶段发货意愿明显偏低,市场普遍采取控货策略。整体而言,在自律议题持续延伸的情况下,短期内硅片价格不排除维持偏强走势。InfoLink数据暂未反映 12月25日的最新调价情况。 据SMM上海有色网分析,本轮硅片涨价有基本面支撑。近期大宗商品金属产品涨价,使得电池组件非硅成本大幅增加,整体光伏主材实际成交重心均在上 移,而硅片环节自身库存水平健康,因此供应偏紧的情况下,价格上调符合市场预期,但具体成交情况仍要看下游接受程度。 证券时报记者从多家硅片厂商人士处证实了今日上调报价的信息,业内普遍反馈,本次硅片涨价主要是上游硅料涨幅较大所致。 市场消息称,12月25日下午,四家头部硅片企业联合大幅上调报价,其中183N硅片报价1.4元/片、210RN报价1.5元/片、210N报价1.7元/片,平均涨幅达到 12%。 ...
京东:采销平均25薪,上不封顶
Zheng Quan Shi Bao· 2025-12-25 09:37
值得注意的是,除京东外,临近年底,多个大厂均有涨薪的消息。 12月19日,字节跳动发布面向全球员工的内部邮件,宣布继续加大人才投入,提高薪酬竞争力、提升期 权激励力度。具体包括四大措施:增加奖金(含绩效期权)投入,2025全年绩效评估周期相比上个周期 提升35%;大幅增加调薪投入,较上个周期提升1.5倍;提高所有职级薪酬总包的下限(起薪)和上限 (天花板)。该公司表示,此举系为确保员工薪酬竞争力和激励回报在全球各个市场都"领先于头部水 平"。 12月22日,针对"比亚迪(002594)技术研发人员涨薪"的消息,比亚迪方面回应称"情况属实",但未对 具体的涨薪幅度做出回应。媒体报道称,根据员工反馈,本次调薪幅度多数在1000元左右,个别可达 3200元,也有部分在数百元不等。公司通常设有多个调薪档次,并执行相应的标准。 此外,在今年12月初,宁德时代(300750)也宣布涨薪,不过与其他公司不同的是,宁德时代的涨薪范 围主要是一线蓝领员工。 12月25日,有京东员工在社交媒体透露,京东年终曝出好消息:京东2025年终奖公告显示,京东全集团 92%的员工将拿满甚至拿到超额年终奖,年终奖总投入同比增幅超过70%,预 ...
午后异动!600779,直线拉升涨停
Zheng Quan Shi Bao· 2025-12-25 09:33
机器人概念爆发 人形机器人概念盘中强势拉升,截至收盘,昊志机电、超捷股份20%涨停,均创出新高;埃夫特、强瑞 技术、拓斯达涨超13%,瑞可达涨近10%。 | 代码 | 名称 | . | 涨幅% | 现价 | 张氏 | 采价 | 卖价 | 总量 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 300203 | 吴志机电 | | 20.01 | 43.42 | 7.24 | 43.42 | | 524466 | | 301005 超捷股份 | | R | 20.00 | 134.93 | 22.49 | 134.93 | | 294689 | | 688165 埃夫特-U | | K | 13.55 | 22.88 | 2.73 | 22.87 | 22.88 | 303187 | | 301128 强瑞技术 | | R | 13.05 | 107.75 | 12.44 | 107.75 | 107.76 | 125339 | | 300607 拓斯达 | | R | 13.01 | 31.96 | 3.68 | 31.95 | 31.96 ...
京东证实:今年年终奖额度同比涨幅超70%
Zheng Quan Shi Bao· 2025-12-25 09:33
近年来,京东不断加大对员工薪酬、福利的投入。薪酬方面,过去一年多的时间里,连续7次多大范围 提高员工薪酬激励。 12月25日,有京东员工在社交媒体透露,京东年终连连曝出好消息:在前一天刚刚给全国各地员工送上 10万盒新年惊喜巧克力后,今天又发布了2025年终奖公告,京东全集团92%的员工拿满甚至拿到超额年 终奖,年终奖总投入同比增幅超过70%,预计将创下行业今年最大涨幅。 对此,证券时报记者从京东方面确认,上述年终奖公告属实。 据记者了解,京东去年9月发布了20薪升级计划,宣布自2024年10月1日起京东零售集团和职能体系将用 两年时间实现20薪,其他部门也将随后陆续启动加薪。根据该加薪计划,今年京东年终奖继续大幅上 涨,已升级部门今年实现19薪,同时更有业务单元提前实现20薪。此外,一线员工年终奖仍将在年前发 放。 据透露出来的公告显示:今年升级为19薪的部门内,年度绩效A+的员工将获得10倍月薪年终奖,即全 年22薪;年度绩效A的员工将获得9倍月薪年终奖,即全年21薪;年度绩效B+的员工将获得7倍月薪年终 奖,即全年19薪。而在今年提前实现20薪的部门内,年度绩效B+的员工即可拿满8倍月薪年终奖,即全 年 ...
云深处科技,完成Pre-IPO轮融资
Zheng Quan Shi Bao· 2025-12-25 09:32
Core Viewpoint - Hangzhou Yunshen Technology Co., Ltd. has completed a Pre-IPO financing round of several hundred million yuan, led by the National Artificial Intelligence Industry Investment Fund and followed by JD.com, following the initiation of its IPO guidance [1][2]. Group 1: Company Overview - Hangzhou Yunshen Technology is one of the "Six Little Dragons" of Hangzhou, focusing on embodied intelligence technology innovation and applications, particularly in quadruped robots, humanoid robots, and core components [2]. - The company was established on November 29, 2017, with a registered capital of 8.234958 million yuan, and its legal representative is Zhu Qiuguo, who controls 32.60% of the shares [4]. Group 2: Financing Activities - The company has undergone a total of 11 financing rounds since its inception, covering the entire lifecycle from angel round to C round and Pre-IPO [5]. - On December 9, 2025, the company announced the completion of over 500 million yuan in C round financing, with participation from various strategic investors including China Telecom and China Unicom [5]. Group 3: IPO Guidance and Future Plans - The IPO guidance period for Hangzhou Yunshen Technology is from December 2025 to June 2026, with plans to solidify guidance results and submit a guidance acceptance application to the regulatory authority [4]. - The company aims to leverage the recent financing to enhance its technology research and development, expand production capacity, and market reach, promoting the commercialization and scaling of embodied intelligence robots across various industries [6].
汽车行业资金流入榜:飞龙股份等12股净流入资金超亿元
Zheng Quan Shi Bao· 2025-12-25 09:05
汽车行业资金流入榜 代码简称今日涨跌幅(%)今日换手率(%)主力资金流量(万元) 沪指12月25日上涨0.47%,申万所属行业中,今日上涨的有25个,涨幅居前的行业为国防军工、轻工制 造,涨幅分别为2.91%、1.59%。汽车行业今日上涨1.46%。跌幅居前的行业为综合、有色金属,跌幅分 别为1.12%、0.77%。 资金面上看,两市主力资金全天净流出181.29亿元,今日有8个行业主力资金净流入,汽车行业主力资 金净流入规模居首,该行业今日上涨1.46%,全天净流入资金27.47亿元,其次是机械设备行业,日涨幅 为1.51%,净流入资金为18.62亿元。 主力资金净流出的行业有23个,电子行业主力资金净流出规模居首,全天净流出资金61.23亿元,其次 是有色金属行业,净流出资金为41.35亿元,净流出资金较多的还有通信、商贸零售、计算机等行业。 汽车行业今日上涨1.46%,全天主力资金净流入27.47亿元,该行业所属的个股共283只,今日上涨的有 224只,涨停的有9只;下跌的有55只。以资金流向数据进行统计,该行业资金净流入的个股有130只,其 中,净流入资金超亿元的有12只,净流入资金居首的是飞龙股份, ...